Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis

Abstract

This study provides Class III evidence that KFLC index or IF can be used to differentiate patients with MS from nonselected controls and from patients with other autoimmune CNS disorders.